Flexible realistic simulation of seizure occurrence recapitulating statistical properties of seizure diaries.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
02 2023
Historique:
revised: 12 11 2022
received: 11 07 2022
accepted: 17 11 2022
pmc-release: 01 02 2024
pubmed: 20 11 2022
medline: 9 2 2023
entrez: 19 11 2022
Statut: ppublish

Résumé

A realistic seizure diary simulator is currently unavailable for many research needs, including clinical trial analysis and evaluation of seizure detection and seizure-forecasting tools. In recent years, important statistical features of seizure diaries have been characterized. These include (1) heterogeneity of individual seizure frequencies, (2) the relation between average seizure rate and standard deviation, (3) multiple risk cycles, (4) seizure clusters, and (5) limitations on inter-seizure intervals. The present study unifies these features into a single model. Our approach, Cyclic Heterogeneous Overdispersed Clustered Open-source L-relationship Adjustable Temporally limited E-diary Simulator (CHOCOLATES) is based on a hierarchical model centered on a gamma Poisson generator with several modifiers. This model accounts for the aforementioned statistical properties. The model was validated by simulating 10 000 randomized clinical trials (RCTs) of medication to compare with 23 historical RCTs. Metrics of 50% responder rate (RR50) and median percent change (MPC) were evaluated. We also used CHOCOLATES as input to a seizure-forecasting tool to test the flexibility of the model. We examined the area under the receiver-operating characteristic (ROC) curve (AUC) for test data with and without cycles and clusters. The model recapitulated typical findings in 23 historical RCTs without the necessity of introducing an additional "placebo effect." The model produced the following RR50 values: placebo: 17 ± 4%; drug 38 ± 5%; and the following MPC values: placebo: 13 ± 6%; drug 40 ± 4%. These values are similar to historical data: for RR50: placebo, 21 ± 10%, drug: 43 ± 13%; and for MPC: placebo: 17 ± 10%, drug: 41 ± 11%. The seizure forecasts achieved an AUC of 0.68 with cycles and clusters, whereas without them the AUC was 0.51. CHOCOLATES represents the most realistic seizure occurrence simulator to date, based on observations from thousands of patients in different contexts. This tool is open source and flexible, and can be used for many applications, including clinical trial simulation and testing of seizure-forecasting tools.

Identifiants

pubmed: 36401798
doi: 10.1111/epi.17471
pmc: PMC9905290
mid: NIHMS1853041
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

396-405

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS102190
Pays : United States
Organisme : NCATS NIH HHS
ID : KL2 TR002542
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG064312
Pays : United States
Organisme : NINDS NIH HHS
ID : L30 NS113085
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS102574
Pays : United States
Organisme : National Science Foundation
ID : 2014431
Organisme : NINDS NIH HHS
ID : KL2TR002542
Pays : United States
Organisme : NINDS NIH HHS
ID : RF1 NS120947
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL161253
Pays : United States
Organisme : NINDS NIH HHS
ID : K23 NS124656
Pays : United States
Organisme : Glenn Foundation for Medical Research
Organisme : NIA NIH HHS
ID : R01 AG073410
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS126282
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS107291
Pays : United States

Informations de copyright

© 2022 International League Against Epilepsy.

Références

Neurology. 2012 Aug 7;79(6):589-96
pubmed: 22843280
Lancet Neurol. 2018 Mar;17(3):279-288
pubmed: 29452687
Epilepsia. 2005 Dec;46(12):1926-36
pubmed: 16393158
Comput Intell Neurosci. 2022 Jun 17;2022:6486570
pubmed: 35755757
Chaos. 2021 Jan;31(1):013138
pubmed: 33754758
J Neurol Sci. 2021 Sep 15;428:117611
pubmed: 34419933
Epilepsy Behav. 2010 Nov;19(3):352-8
pubmed: 20937567
Epilepsia. 2010 Jun;51(6):958-67
pubmed: 20132285
Curr Opin Neurol. 2015 Apr;28(2):143-50
pubmed: 25695133
Nat Commun. 2018 Jan 8;9(1):88
pubmed: 29311566
Lancet Neurol. 2021 Feb;20(2):127-135
pubmed: 33341149
Neurology. 2007 Apr 10;68(15):1197-204
pubmed: 17420403
Epilepsy Behav. 2016 Aug;61:224-230
pubmed: 27376872
Lancet Neurol. 2021 Dec;20(12):1038-1047
pubmed: 34710360
JAMA Neurol. 2021 Apr 1;78(4):454-463
pubmed: 33555292
Epilepsia. 2019 Dec;60(12):e128-e132
pubmed: 31724165
Epilepsia. 2011 Feb;52(2):219-33
pubmed: 21269281
Epilepsia. 2021 Feb;62 Suppl 1:S2-S14
pubmed: 32712968
Epilepsy Behav. 2018 Nov;88:349-356
pubmed: 30344026
Epilepsy Res. 2020 Jul;163:106330
pubmed: 32305858
Epilepsia. 2015 Oct;56(10):1515-23
pubmed: 26336950
Epilepsia. 2004 Jan;45(1):20-7
pubmed: 14692903
Ann Neurol. 2020 Sep;88(3):588-595
pubmed: 32567720
Neurology. 2005 Dec 13;65(11):1737-43
pubmed: 16344515
Seizure. 2019 May;68:9-15
pubmed: 29871784
Front Neurol. 2022 Aug 22;13:938294
pubmed: 36071898
Epilepsia. 2007 Jul;48(7):1308-17
pubmed: 17635557
Neurology. 1994 Aug;44(8):1403-7
pubmed: 8058138
Epilepsy Behav. 2010 Oct;19(2):100-4
pubmed: 20692877
Epilepsia Open. 2017 Jun;2(2):156-161
pubmed: 28758158
Lancet Neurol. 2012 Sep;11(9):827-34
pubmed: 22898736
Epilepsia. 2013 Jan;54(1):117-25
pubmed: 22905857
Ann Clin Transl Neurol. 2018 Jan 09;5(2):201-207
pubmed: 29468180
Seizure. 2021 Oct;91:499-502
pubmed: 34365104
Neurology. 2003 May 27;60(10):1631-7
pubmed: 12771254
Neurology. 2007 Oct 16;69(16):1610-8
pubmed: 17938371
Epileptic Disord. 2019 Aug 1;21(4):319-329
pubmed: 31403463
Ann Clin Transl Neurol. 2017 May 24;4(8):544-552
pubmed: 28812044
Neurology. 2005 Feb 8;64(3):475-80
pubmed: 15699378
Lancet Neurol. 2013 Jun;12(6):563-71
pubmed: 23642342
Epilepsia. 2015 Dec;56(12):1890-8
pubmed: 26471380
Ann Neurol. 2015 Sep;78(3):329-36
pubmed: 26150090
Epilepsia. 2009 Mar;50(3):443-53
pubmed: 19183227
Epilepsy Res. 2017 Nov;137:145-151
pubmed: 28781216
Epilepsia. 2020 Aug;61(8):1659-1667
pubmed: 32658327
Epilepsy Res. 2010 Sep;91(1):10-9
pubmed: 20696552
PLoS Med. 2008 Aug 12;5(8):e166
pubmed: 18700812
Epilepsia Open. 2018 Jul 04;3(3):364-373
pubmed: 30187007
Epilepsy Res. 2020 May;162:106306
pubmed: 32172145
Epilepsia. 2009 Mar;50(3):464-74
pubmed: 19222545
Neurology. 2011 May 3;76(18):1555-63
pubmed: 21451152
Epilepsia. 1991 Sep-Oct;32(5):642-9
pubmed: 1915170
Curr Opin Neurol. 2018 Apr;31(2):162-168
pubmed: 29369115
Neurology. 2010 Nov 16;75(20):1817-24
pubmed: 20944074
Lancet Neurol. 2018 Nov;17(11):977-985
pubmed: 30219655
Neurology. 2017 Apr 25;88(17):1674-1680
pubmed: 28438841
Seizure. 2017 Dec;53:31-36
pubmed: 29102709
Neurology. 2007 Oct 30;69(18):1751-60
pubmed: 17625106
Epilepsia. 2014 Jan;55(1):47-56
pubmed: 24256083
Epilepsia. 2017 May;58(5):835-844
pubmed: 28369781
Neurology. 2012 May 1;78(18):1408-15
pubmed: 22517103
Epilepsia. 2014 Jan;55(1):57-66
pubmed: 24446953
Front Neurol. 2021 Feb 16;12:636045
pubmed: 33664705

Auteurs

Daniel M Goldenholz (DM)

Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.

M Brandon Westover (MB)

Department of Neurology, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA.
Department of Neurology, Harvard Medical School, Boston, Massachusetts, USA.
Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.
McCance Center for Brain Health, Boston, Massachusetts, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH